BioHealth News Archive
Altimmune Receives Award from U.S. Department of Defense to Fund Phase 1/2 Clinical Trial of T-COVID™ in Outpatients with Early COVID-19 | BioSpace
GAITHERSBURG, Md., June 29, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced it was awarded $4.7 million from…
Read More
Center for Innovative Technology names this year’s grant recipients – The Virginian-Pilot – Inside Business
A drug company trying to save infants’ lives, a university center protecting hospitals from hackers, a tech company building extreme drones: three groups in…
Read More
The race to find a COVID-19 vaccine – CBS News
It's not an understatement to say that the entire nation's hopes are focused on what's happening in a Maryland laboratory – step one in…
Read More
AstraZeneca leading the Covid-19 vaccine race; may get results quite early: WHO – The Hindu BusinessLine
The World Health Organization said on Friday that AstraZeneca's experimental Covid-19 vaccine is the world’s leading candidate and reached the final stage in terms…
Read More
BioHealth Capital Region M&A Roundup First Half of 2020 · BioBuzz
It has been a tumultuous 2020 for venture capital and mergers and acquisitions due to the market uncertainty sparked by the onset of the…
Read More
With cell and gene therapy boom coming, experts at Novartis, Kite trumpet need for capacity | FiercePharma
Cell and gene therapy has evolved into one of the biopharma industry's hottest markets, with a major splash of investment and a run of…
Read More
Novavax Expands Executive Leadership and Announces Key Promotions | Novavax Inc. – IR Site
GAITHERSBURG, Md., June 29, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced…
Read More
MedTech Innovator Announces Top 50 Medtech Startups Selected for Annual Showcase and Accelerator | Business Wire
LOS ANGELES--(BUSINESS WIRE)--MedTech Innovator, the premier nonprofit accelerator in the medical technology industry, today announced the 50 companies selected to participate in the organization’s…
Read More
Charles Andres and Christian Barrow join BioTalk to discuss investing, growth and the BioHealth Capital Region during COVID-19
Charles Andres, Ph.D., RAC, Associate at Wilson Sonsini Goodrich & Rosati, and Christian Barrow, Executive Director, Life Sciences Banking at JP Morgan, join Rich…
Read More
The BioHealth Capital Region Featured at Digital RESI LSN Global Conference
The Life Science Network's Digital Redefining Early State Investments (RESI) took place online June 8-10, 2020, and featured some of the most knowledgeable voices…
Read More
CrazyCap helps Martine Rothblatt Cheer On Her Team Through Crisis! – PharmiWeb.com
MIAMI, June 22, 2020 /PRNewswire/ -- Esteemed lawyer, author, and entrepreneur, Martine Rothblatt, Ph.D., found a thoughtful and practical way to thank her employees at…
Read More
Preclinical Data for PRGN-3005 UltraCAR-T® Demonstrate Superior Expansion and Persistence of UltraCAR-T Compared to Traditional CAR-T | BioSpace
GERMANTOWN, Md., June 22, 2020 /PRNewswire/ -- Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the…
Read More
Altimmune Announces IND Clearance for a Phase 2 Trial of HepTcell™ Immunotherapeutic for the Treatment of Chronic Hepatitis B | BioSpace
GAITHERSBURG, Md., June 22, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug…
Read More
Emergent to add gene therapy capacity – Bioprocess InsiderBioProcess International
Emergent Biosolutions has set out to capture a share of the expanding viral vector and gene therapy sector. The US countermeasures developer said it…
Read MoreBIA | EPIDAREX CAPITAL CLOSES NEW £102 MILLION UK VENTURE FUND TO BUILD SUCCESSFUL LIFE SCIENCE COMPANIES
Edinburgh, UK, 22 June 2020 - Epidarex Capital (“Epidarex”), a transatlantic life science venture firm, announces that it has closed Epidarex Capital III UK…
Read More